Bermejo Vega, Nuria | Hematología y Hemoterapia |

Resultados: 118
Tipo Título / Nombre Autor(es) Año
Early Treatment Use of Fostamatinib for Immune Thrombocytopenia (ITP): Efficacy and Safety As Second/Third ITP Treatment Lines in Clinical Practice in Spain González López TJ, Bermejo Vega N, Cardesa Cabrera R., Acedo Domínguez N 2024
Perioperative management of a series of patients with hereditary factor X deficiency Patiño Culma DC, Bermejo N, Calzadilla K, Casado Cabanillas V, Valderrama Rosa A, Casas Avilés I, Higuero Saavedra V, Román Molano L 2024
Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice González-López TJ, Bermejo N, Cardesa-Cabrera R, Martínez V, Aguilar-Monserrate G, Pérez Segura G, García AD, Luis-Navarro J, Lakhwani S, Acedo N, Lozano ML, Bernat S, Torres-Tienza A, Ruano A, Jarque I, Galán Alvarez P, Benet Campos C, Marcellini-Antonio S, Jimenez-Bárcenas R, Martínez-Carballeira D, de Miguel Llorente D, Perona Blázquez Á, González-Gascón-Y-Marín I, Lopez-Ansoar E, Alonso Alonso JM, Bengochea-Casado ML, Díaz Gálvez FJ, Moretó A, Moreno G, Hernández-Martin R, de Cabo E, Davila-Valls J, Cuesta A, Pastoriza Cruz C, Hermida G, Pozas-Mañas MA, Aguilar-Franco C, Fernandez-Jimenez D, Navas-Elorza B, López-Santamaría Castro C, Lorenzo Vizcaya A, Ortín X, Pintos MG, Piernas S, Díaz-Santa J, Soto-Ortega I Dr, Provan D, García-Donas Gabaldón G 2024
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC Gresele P, Falcinelli E, Bury L, Alessi MC, Guglielmini G..., Bermejo N 2024
Thrombotic profile of a serie of 14 patients carrying 67ARG>STOP polymorphism in the Serpine A10 (protase-dependent protein Z inhibitor) gene Bermejo N, Casado Cabanillas V, González Valero JM, Higuero V, Ibañez Espacio F 2023
Multi-center evaluation of light transmission platelet aggregation reagents: Communication from the ISTH SSC Subcommittee on Platelet Physiology Alessi MC, Coxon C, Ibrahim-Kosta M, Bacci M, Voisin S..., Bermejo N 2023
Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM..., Bermejo N, López-Fernández MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, Revilla N, González-Porras JR, Bolaños E, Rodríguez-López MA, Orna-Montero E, Vicente V 2021
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Álvarez RM..., Bermejo N, López-Fernández MF, de Andrés A, Valcarcel D, Casado-Montero LF, Álvarez-Roman MT, Orts MI, Novelli S, González-Porras JR, Bolaños E, López-Ansoar E, Orna-Montero E, Vicente V 2021
A novel genetic variant in PTGS1 affects N-glycosylation of cyclooxygenase-1 causing a dominant-negative effect Palma-Barqueros V, Crescente M, de la Morena ME, Chan MV, Almarza E, Revilla N, Bohdan N, Miñano A, Padilla J, Allan HE, Maffucci T, Edin ML, Zeldin DC, Mesa-Nuñez C, Damian C, Marín-Quilez A, Benito R, Martínez-Martínez I, Bermejo N, Casas-Aviles I, Alen AR, González-Porras JR, Hernández-Rivas JM, Vicente V, Corral J, Lozano ML, Warner TD, Bastida JM, Rivera J 2021
Caracterización molecular de los trastornos raros de la coagulación. Estudio multicéntrico Rey Búa B, Bermejo N, Calvo Villas JM, Martín-Salces M, Rodríguez Alén A, Dávila J, Pérez Sánchez M, &10, Martín Antorán JM, García Díaz C, Benito R, Herrero S, Del Rey M, González T, Hernández-Rivas JM, González-Porras JR, Bastida JM 2020